Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 7/20 | 0.36 |
| ▸ | SCD | O00767 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4183030 | 1.00 | KIF11 (0.36) | KIF11SCDHIF1AMMP2FNTA | |
| SCHEMBL1667518 | 0.74 | KIF11 (0.39) | KIF11SCDFNTAFNTB | |
| SCHEMBL1667521 | 0.74 | KIF11 (0.39) | KIF11SCDFNTAFNTB | |
| SCHEMBL14713213 | 0.69 | BACE1 (0.37) | — | |
| SCHEMBL29288708 | 0.69 | SCD (0.32) | SCDHIF1A | |
| SCHEMBL16499182 | 0.69 | MAOB (0.34) | SCD | |
| SCHEMBL10601488 | 0.69 | MAOB (0.33) | SCD | |
| SCHEMBL31742548 | 0.69 | MAOB (0.33) | SCD | |
| SCHEMBL5182985 | 0.68 | CYP2C9 (0.36) | SCD | |
| SCHEMBL7919906 | 0.68 | MAOB (0.35) | SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190345505-A1 | METHODS FOR REGULATING EXTRACTABLE PROANTHOCYANIDINS (PAS) IN PLANTS BY AFFECTING LEUCOANTHOCYANIDIN REDUCTASE (LAR) | UNIVERSITY OF NORTH TEXAS (US) | 2019-11-14 | — | — | US | disclosed |
| CN-102933569-A | Method of preparing derivatives/oligomers of epicatechin and applications thereof | UNIV SINGAPORE | 2013-02-13 | — | — | CN | disclosed |
| US-20120323016-A1 | METHOD OF PREPARING DERIVATIVES/OLIGOMERS OF EPICATECHIN AND APPLICATIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2012-12-20 | — | — | US | disclosed |
| EP-1524270-B1 | SULFUR-CONTAINING PROANTHOCYANIDIN OLIGOMER COMPOSITION AND PROCESS FOR PRODUCING THE SAME | AMINO UP CHEMICAL CO LTD (JP) | 2009-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120323016-A1 | METHOD OF PREPARING DERIVATIVES/OLIGOMERS OF EPICATECHIN AND APPLICATIONS THEREOF | OSTC, PROC, C9 | KIF11 948/4885SCD 902/4885HIF1A 3845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.